000 01514 a2200469 4500
005 20250513193316.0
264 0 _c19991118
008 199911s 0 0 eng d
022 _a1042-8194
024 7 _a10.3109/10428199909145713
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBieri, S
245 0 0 _aPrimary mediastinal large B-cell lymphoma (PMLCL): the need for prospective controlled clinical trials.
_h[electronic resource]
260 _bLeukemia & lymphoma
_cSep 1999
300 _a139-46 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xtherapeutic use
650 0 4 _aControlled Clinical Trials as Topic
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLymphoma, B-Cell
_xdrug therapy
650 0 4 _aLymphoma, Large B-Cell, Diffuse
_xdrug therapy
650 0 4 _aMale
650 0 4 _aMediastinal Neoplasms
_xdrug therapy
650 0 4 _aMiddle Aged
650 0 4 _aProspective Studies
650 0 4 _aRetrospective Studies
650 0 4 _aTreatment Outcome
700 1 _aRoggero, E
700 1 _aZucca, E
700 1 _aBertoni, F
700 1 _aPianca, S
700 1 _aSanna, P
700 1 _aPedrinis, E
700 1 _aBernier, J
700 1 _aCavalli, F
773 0 _tLeukemia & lymphoma
_gvol. 35
_gno. 1-2
_gp. 139-46
856 4 0 _uhttps://doi.org/10.3109/10428199909145713
_zAvailable from publisher's website
999 _c10469229
_d10469229